Inspra
Links shared publicly online about this topic
Inspra performs strongly in heart failure patients | InPharm
inpharm.com — “Inspra performs strongly in heart failure patients | InPharm” View full resource at inpharm.com
Most Recently Shared on May 28, 2010 at 9:07 am By:
Pharmafocus Pharma and Health News
Pfizer's Inspra performs strongly in heart failure patients http://ht.ly/1R2GL
Diuretic Inspra sharply reduces deaths in patients with mild heart failure - latimes.com
latimes.com — “The diuretic Inspra can reduce deaths and hospitalizations for mild heart failure by 37%, researchers said Sunday, indicating that the drug or others in the class should be more widely used for treating the condition. Inspra, known generically as eplerenone, and the related drug spironolactone are already used to treat patients with more severe heart failure, but the new study, presented at a Chicago meeting of the American Heart Assn. and published online in the New England Journal of Medicine ” View full resource at latimes.com
Most Recently Shared on November 14, 2010 at 11:16 pm By:
LA Times Health News Health News
Diuretic Inspra sharply reduces deaths in patients with mild heart failure http://lat.ms/b9L1Jq
Pfizer Inc. Halts Heart Failure Trial Enrollment for Inspra on Early Success - News, Search Jobs, Events
biospace.com — “Pfizer Inc. Halts Heart Failure Trial Enrollment for Inspra on Early Success - News, Search Jobs, Events” View full resource at biospace.com
Most Recently Shared on May 30, 2010 at 1:29 am By:
Victor Montori, MD Physician, Doctor, Internist, Research, and Endocrinologist
EMPHASIS-HF - http://www.biospace.com/news_story.aspx?NewsEntityId=182057&Source=TopBreaking
Adding Inspra(R) (Eplerenone) To Standard Therapy Reduces The Incidence Of New Onset AF/F In Patients With Systolic Heart Failure, Sub-Analysis Shows
medicalnewstoday.com — “Pfizer Inc. (NYSE: PFE) today announced results from a pre-specified sub-analysis1 of the EMPHASIS-HF trial2 which showed that Inspra® (eplerenone), added to standard recommended therapy, stat” View full resource at medicalnewstoday.com
Most Recently Shared on May 23, 2011 at 12:05 pm By:
MNT Cardiovascular Health News
Adding Inspra(R) (Eplerenone) To Standard Therapy Reduces The Incidence Of New Onset AF/F In Patients With Systolic He... http://mnt.to/3WcC
Diuretic Pill Cuts Deaths in Heart Failure Patients
webmd.com — “The diuretic pill Inspra substantially cut the risk of death and hospitalization among people with mild heart failure, researchers report.” View full resource at webmd.com
Most Recently Shared on November 15, 2010 at 8:13 pm By:
Diuretic Pill Cuts Deaths in Heart Failure Patients: The diuretic pill Inspra substantially cut the risk of deat... http://bit.ly/am11YF
Epleronone Shown To Reduce Atrial Fibrillation
medicalnewstoday.com — “The aldosterone antagonist eplerenone (Inspra, Pfizer) significantly reduced the development of new onset atrial fibrillation and flutter (AFF) in patients with class 2 heart failure, concludes a” View full resource at medicalnewstoday.com
Most Recently Shared on May 23, 2011 at 9:57 am By:
Epleronone Shown To Reduce Atrial Fibrillation: The aldosterone antagonist eplerenone (Inspra, Pfizer) significa... http://bit.ly/lSOiwQ
Pfizer heart-failure drug helps milder patients: study
health.yahoo.net — “People with mild heart failure lived longer and fared better by adding Pfizer's drug Inspra to standard medications, a finding that could widely expand use of such drugs in healthier patients, researchers said on Sunday.” View full resource at health.yahoo.net
Most Recently Shared on November 14, 2010 at 7:10 pm By:
Jennifer Ann Grisso Nurse and Active Health Library
Pfizer heart-failure drug helps milder patients: study: People with mild heart failure lived longer and fared be... http://bit.ly/9iXou4
Pfizer heart-failure drug helps milder patients: study
health.yahoo.net — “People with mild heart failure lived longer and fared better by adding Pfizer's drug Inspra to standard medications, a finding that could widely expand use of such drugs in healthier patients, researchers said on Sunday.” View full resource at health.yahoo.net
Most Recently Shared on November 14, 2010 at 7:07 pm By:
Jane Anderson Healthy Eating Advisor
Pfizer heart-failure drug helps milder patients: study http://bit.ly/8Ypg0r
Blood Pressure Drug Helps Those With Mild Heart Failure - MSN Health - Heart & Cardiovascular
health.msn.com — “Inspra reduced cardiovascular complications including irregular heart rhythm” View full resource at health.msn.com
Most Recently Shared on May 22, 2011 at 8:40 pm By:
Bruce McLucas, MD ObGyn Physician, Surgeon, Physician, and Doctor
Blood Pressure Drug Helps Those With Mild Heart Failure http://ow.ly/1cOdZA
Eplerenone in mild HF trial stopped early due to drug benefit
theheart.org — “Pfizer is to halt recruitment of patients to the EMPHASIS-HF trial testing its selective aldosterone inhibitor eplerenone in mild heart-failure patients because of a significant benefit of the drug.” View full resource at theheart.org
Most Recently Shared on May 28, 2010 at 3:42 pm By:
Pfizer halts eplerenone HF trial early due to drug benefit: Pfizer is to halt recruitment of patients to the EMPHA... http://bit.ly/adkX5w
Medical News: AHA: Diuretic Cuts Morbidity, Mortality in Mild HF - in Meeting Coverage, AHA from MedPage Today
medpagetoday.com — “CHICAGO -- Mildly symptomatic heart failure patients have better outcomes with the selective aldosterone-receptor blocker eplerenone (Inspra), a randomized controlled trial showed.” View full resource at medpagetoday.com
Most Recently Shared on November 15, 2010 at 1:31 pm By:
Yvo Sijpkens MD Nephrologist, Physician, Doctor, and Internist
Diuretic Cuts Morbidity, Mortality in Mild HF (CME/CE) http://bit.ly/chPhdr
Symposier - Diuretic Prevents Atrial Arrhythmias in Heart Failure
symposier.com — “Uploaded and shared in Youtube by: MedPageToday — GOTHENBURG, Sweden -- The selective aldosterone-receptor blocker eplerenone (Inspra) reduces incidence of atrial fibrillation or flutter in mildly symptomatic systolic heart failure patients, according to an EMPHASIS-HF subanalysis.” View full resource at symposier.com
Most Recently Shared on June 6, 2011 at 10:10 pm By:
Symposier Cardiology Cardiology and Health Business
Diuretic(eplerenone, Inspra) Prevents Atrial Arrhythmias in Heart Failure. http://bit.ly/jO8QvF
Epleronone Shown To Reduce Atrial Fibrillation
medicalnewstoday.com — “The aldosterone antagonist eplerenone (Inspra, Pfizer) significantly reduced the development of new onset atrial fibrillation and flutter (AFF) in patients with class 2 heart failure, concludes a” View full resource at medicalnewstoday.com
Most Recently Shared on May 23, 2011 at 8:05 am By:
MNT Cardiovascular Health News
Epleronone Shown To Reduce Atrial Fibrillation http://mnt.to/3WbK #cardiovascular
Pfizer heart-failure drug helps milder patients: study | Reuters
reuters.com — “CHICAGO (Reuters) - People with mild heart failure lived longer and fared better by adding Pfizer's drug Inspra to standard medications, a finding that could widely expand use of such drugs in healthier” View full resource at reuters.com
Most Recently Shared on November 14, 2010 at 7:04 pm By:
Pfizer heart-failure drug helps milder patients: study: CHICAGO (Reuters) - People with mild heart failure lived... http://bit.ly/9zNqhe
Pfizer heart-failure drug helps milder patients: study | Reuters
reuters.com — “CHICAGO (Reuters) - People with mild heart failure lived longer and fared better by adding Pfizer's drug Inspra to standard medications, a finding that could widely expand use of such drugs in healthier” View full resource at reuters.com
Most Recently Shared on November 14, 2010 at 6:30 pm By:
Pfizer heart-failure drug helps milder patients: study http://dlvr.it/8X3Rb
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
Pharmafocus
Monthly pharmaceutical, biotech & healthcare news publication for Europe. For pharma & biotech jobs follow @inpharmjobs. Twitter accounts run by @dominic_tyer
-
LA Times Health News
Current health + medical news from the Los Angeles Times + latimes.com. See latimes.com/twitter for more news + features streams.
-
Victor Montori, MD
Mayo Clinic diabetes doc + researcher from Peru working for a patient revolution vs. healthcare corruption, and for treatments that fit patients.
Advertisement
